GSK2245035 is a potent and selective intranasal TLR7 agonist that preferentially induces Type-1 interferon (IFNalpha) over TNFalpha. It is utilized in immunology research to study antiviral responses and allergic inflammation, having been shown to inhibit Th2 cytokine production in human cell-based assays.
Molekulargewicht:
390.52
CAS Nummer:
[1207629-49-9]
Formel:
C20H34N6O2
Target-Kategorie:
Others,TNF,IFNAR,TLR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten